In the first Federal Circuit case involving the Biologics Price Competition and Innovation Act (“BPCIA” or “Biosimilars Act”), the Court of Appeals for the Federal Circuit affirmed Judge Maxine E….
In a recent lawsuit between a biosimilar applicant and a patent owner, Judge Paul A. Crotty (S.D.N.Y.) relied on Sandoz Inc. v. Amgen Inc., 3:13-cv-02904-MMC (N.D. Cal. Nov. 12, 2013)…
Partner Joseph Re was recognized by Law360 as an “IP MVP”. Read below for the full story. IP MVP: Knobbe Martens’ Joseph Re | Law360 from Knobbe Martens Olson &…
The Board recently added an order in Corning Optical Communications RF, LLC v. PPC Broadband, Inc., IPR2014-00441, to its list of Representative Decisions on Motion to Amend on the Board’s…
Partner Joseph Re wrote an article for the Orange County Business Journal discussing the importance of our patent system. Read below for the full story. Why We Need Our Patent…
Why It’s Important The Ultramercial decision will provide an additional tool in invalidating overly broad software-based patents. It also underscores the value of carefully crafting software patents, as those patents…
Partner John Sganga was interviewed by the Daily Journal for an article discussing the decrease of patent lawsuits. Read below for the full story. Patent Suit Drop Has Lawyers Mulling…
Guest Post by Brent M. Dougal and Philip M. Nelson on Patently-O. Dougal and Nelson are Partners in our Orange County office. In today’s age of international commerce, product development often takes…
Knobbe, Martens, Olson & Bear LLP has scored a $466.7 million verdict for its client, Irvine-based medical technology company Masimo Corp., in a patent infringement case against Philips Electronic North…
The AIA sets a one-year deadline to file a petition for IPR of a patent from the date a complaint for patent infringement is served. 35 U.S.C. § 315(b). There is…
